Loading clinical trials...
Loading clinical trials...
It has been shown in the literature that urinary CA19-9 levels are associated with the degree of hydronephrosis and the anteroposterior diameter of the renal pelvis. Additionally, this marker has been...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Marmara University
NCT07377929 · Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms
NCT07507331 · Neurogenic Bladder Disorder, Spinal Cord Injury, and more
NCT01589263 · Benign Prostatic Hyperplasia, Lower Urinary Track Symptoms
Marmara University School of Medicine Urology Department
Istanbul, Istanbul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions